127 related articles for article (PubMed ID: 26485930)
1. Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.
Muthu M; Somagoni J; Cheriyan VT; Munie S; Levi E; Ashour AE; Yassin AE; Alafeefy AM; Sochacki P; Polin LA; Reddy KB; Larsen SD; Singh M; Rishi AK
J Biomed Nanotechnol; 2015 Sep; 11(9):1608-27. PubMed ID: 26485930
[TBL] [Abstract][Full Text] [Related]
2. CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.
Cheriyan VT; Muthu M; Patel K; Sekhar S; Rajeswaran W; Larsen SD; Polin L; Levi E; Singh M; Rishi AK
Oncotarget; 2016 Nov; 7(45):73370-73388. PubMed ID: 27687593
[TBL] [Abstract][Full Text] [Related]
3. A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers.
Cheriyan VT; Alsaab H; Sekhar S; Venkatesh J; Mondal A; Vhora I; Sau S; Muthu M; Polin LA; Levi E; Bepler G; Iyer AK; Singh M; Rishi AK
Oncotarget; 2018 Jul; 9(51):29680-29697. PubMed ID: 30038713
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.
Muthu M; Cheriyan VT; Munie S; Levi E; Frank J; Ashour AE; Singh M; Rishi AK
PLoS One; 2014; 9(7):e102567. PubMed ID: 25033461
[TBL] [Abstract][Full Text] [Related]
5. CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth.
Ashour AE; Jamal S; Cheryan VT; Muthu M; Zoheir KM; Alafeefy AM; Abd-Allah AR; Levi E; Tarca AL; Polin LA; Rishi AK
PLoS One; 2013; 8(6):e66733. PubMed ID: 23826121
[TBL] [Abstract][Full Text] [Related]
6. CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.
Jamal S; Cheriyan VT; Muthu M; Munie S; Levi E; Ashour AE; Pass HI; Wali A; Singh M; Rishi AK
PLoS One; 2014; 9(3):e89146. PubMed ID: 24598827
[TBL] [Abstract][Full Text] [Related]
7. CARP-1/CCAR1: a biphasic regulator of cancer cell growth and apoptosis.
Muthu M; Cheriyan VT; Rishi AK
Oncotarget; 2015 Mar; 6(9):6499-510. PubMed ID: 25894788
[TBL] [Abstract][Full Text] [Related]
8. A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma.
Cheriyan VT; Alsaab HO; Sekhar S; Stieber C; Kesharwani P; Sau S; Muthu M; Polin LA; Levi E; Iyer AK; Rishi AK
Oncotarget; 2017 Dec; 8(62):104928-104945. PubMed ID: 29285223
[TBL] [Abstract][Full Text] [Related]
9. PTHrP attenuates osteoblast cell death and apoptosis induced by a novel class of anti-cancer agents.
Chukkapalli S; Levi E; Rishi AK; Datta NS
Endocrine; 2016 Mar; 51(3):534-44. PubMed ID: 26260694
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
11. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
12. Transactivator of transcription-tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo.
Zhang L; Levi E; Majumder P; Yu Y; Aboukameel A; Du J; Xu H; Mohammad R; Hatfield JS; Wali A; Adsay V; Majumdar AP; Rishi AK
Mol Cancer Ther; 2007 May; 6(5):1661-72. PubMed ID: 17513614
[TBL] [Abstract][Full Text] [Related]
13. Novel strategies to target chemoresistant triple-negative breast cancer.
Venkatesh J; Rishi AK; Reddy KB
Genes Cancer; 2020 Dec; 11(3-4):95-105. PubMed ID: 33488948
[TBL] [Abstract][Full Text] [Related]
14. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
[TBL] [Abstract][Full Text] [Related]
15. The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract][Full Text] [Related]
16. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
17. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
[TBL] [Abstract][Full Text] [Related]
18. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
19. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
[TBL] [Abstract][Full Text] [Related]
20. A H2AX⁻CARP-1 Interaction Regulates Apoptosis Signaling Following DNA Damage.
Sekhar SC; Venkatesh J; Cheriyan VT; Muthu M; Levi E; Assad H; Meister P; Undyala VV; Gauld JW; Rishi AK
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30769864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
